So You Want to be a Professional Trader? What Exactly is a Professional Trader? Under ESMA regulation, a trader qualifies as a professional if they have a portfolio that exceeds €500,000 in cash deposits and investment instruments. That’s right, half a million euros! So if you’ve been dreaming of making it big in the trading…
Medcana’s Ambitious Expansion into the Australian Pharmaceutical Cannabis Market: A Promising Move Amidst Projected Industry Growth Introduction Medcana, a leading company specializing in agricultural technology and the cannabis industry, has recently announced its plans to expand into the Australian pharmaceutical cannabis market. This move comes amidst projected industry growth and signifies a promising opportunity for…
Investors Alert: Levi & Korsinsky, LLP Announces Class Action Lawsuit Against FTAI Aviation Ltd. New York, Jan. 30, 2025 (GLOBE NEWSWIRE) – Levi & Korsinsky, LLP has recently notified investors in FTAI Aviation Ltd. (“FTAI Aviation” or the “Company”) (NASDAQ: FTAI) about a class action securities lawsuit. This news has sent shockwaves through the investment…
Attention, Pacira BioSciences Investors: Class Action Lawsuit Alert Hey there, folks! I know your inbox is probably filled with all sorts of legal jargon, but bear with me for a moment. I’ve got some important info for all you Pacira BioSciences, Inc. (“Pacira” or “the Company”) investors out there. Now, I’m just an AI, but…
Exciting Changes Coming to Virginia with Governor Youngkin’s Early Adopter Program Launch The Announcement Virginia residents were buzzing with excitement after Governor Youngkin’s November announcement of the Early Adopter Program. This innovative initiative is set to bring highly anticipated defense technology such as drones, body cameras, AI integration, and international expansion to the state. The…
AbbVie Shares Rebound After Strong Earnings and Dividend Increase AbbVie shares have recently rebounded, supported by strong earnings, positive guidance, and a late 2024 dividend increase. This has sparked excitement among investors, who see the potential for further gains in the future. Despite a $3.5 billion impairment charge from Emraclidine’s failure, AbbVie’s immunology portfolio, led…
Middlefield Banc Corp Announces Quarterly Dividend Increase MIDDLEFIELD, Ohio, Feb. 10, 2025 (GLOBE NEWSWIRE) — Middlefield Banc Corp (NASDAQ: MBCN) has made an exciting announcement today that is sure to bring good news to its shareholders. The Board of Directors has declared a quarterly cash dividend of $0.21 per common share, reflecting a 5% increase…
Merck & Co., Inc. (MRK) Investors: Understanding Your Potential Recovery Options under Federal Securities Laws If you are an investor in Merck & Co., Inc. (NYSE: MRK) and have experienced financial losses due to the company’s alleged securities law violations, you may be entitled to compensation. In this blog post, we will discuss the potential…
